Infectious morbidity in long‐term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts

Survivors of allogeneic marrow transplants are immunodeficient for at least 1 year after grafting. Multiple defects of immunity have been found; however, it is not known which defect primarily accounts for the high infectious morbidity of these patients. Twenty‐nine allograft recipients who were in complete remission of the original disease were examined for the following parameters of immunity at 1 year after transplant: infection score (gauging the number and severity of infections within the 6 months prior to the annual exam), serum total IgM, IgG, and IgA, anti‐Haemophilus influenzae IgG, anti‐Streptococcus pneumoniae IgG, skin test reactivity, and the blood counts of B cells, CD4+ T cells, CD8+ T cells, and their subsets. THe only parameter inversely correlated with the infection score was CD4+ T cell count (P = 0.005 in univariable analysis, P = 0.06 in multivariable analysis). We conclude that infectious morbidity of long‐term transplant survivors is related to the reconstitution of CD4+ T cells. Am. J. Hematology 54:131–138, 1997 © 1997 Wiley‐Liss, Inc.

[1]  K. Weinberg,et al.  Immunological reconstitution following bone marrow transplantation , 1997, Immunological reviews.

[2]  R. Hirschtick,et al.  Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group. , 1995, The New England journal of medicine.

[3]  R. Storb,et al.  T cell reconstitution after bone marrow transplantation into adult patients does not resemble T cell development in early life. , 1995, Bone marrow transplantation.

[4]  Makiko Kobayashi,et al.  CD4+ contrasuppressor T cells improve the resistance of thermally injured mice infected with HSV , 1995, Journal of leukocyte biology.

[5]  R. Storb,et al.  Low IgG production by mononuclear cells from marrow transplant survivors and from normal neonates is due to a defect of B cells. , 1995, Bone marrow transplantation.

[6]  M. Mozes,et al.  Cytotoxic T-cell role in renal allograft rejection and regulation. Renal allograft infiltrating cytotoxic T-cell line with suppressor-inducer function. , 1995, Human immunology.

[7]  S. Steinberg,et al.  Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. , 1995, The New England journal of medicine.

[8]  D. Herndon,et al.  Glycyrrhizin (20β-carboxy-11-oxo-30-norolean-12-en-3β-yl-2-O-β-d-glucopyranuronosyl-α-d-glucopyranosiduronic acid) improves the resistance of thermally injured mice to opportunistic infection of herpes simplex virus type 1 , 1995 .

[9]  J. Hermans,et al.  Clonal dysregulation of the antibody response to tetanus-toxoid after bone marrow transplantation. , 1994, Blood.

[10]  J. Braun,et al.  Abundance of a restricted fetal B cell repertoire in marrow transplant recipients. , 1994, Bone marrow transplantation.

[11]  T. Ishikawa,et al.  The Metabolic Topography of Parkinsonism , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[12]  T. Waldmann,et al.  Treatment of acute graft-versus-host disease with humanized anti-Tac: an antibody that binds to the interleukin-2 receptor. , 1994, Blood.

[13]  L. Hammarström,et al.  Salivary and serum immunoglobulins in recipients of transplanted allogeneic and autologous bone marrow. , 1994, Bone marrow transplantation.

[14]  H. Deeg,et al.  Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia. , 1994, Blood.

[15]  R. Lechler,et al.  Anergic T cells as suppressor cells in vitro. , 1994, Science.

[16]  A. Barrett,et al.  Allogeneic Bone Marrow Transplantation for Chronic Myeloid Leukemia Using Sibling and Volunteer Unrelated Donors: A Comparison of Complications in the First 2 Years , 1993, Annals of Internal Medicine.

[17]  L. Lanier,et al.  CD28- T lymphocytes. Antigenic and functional properties. , 1993, Journal of immunology.

[18]  L. Picker,et al.  Control of lymphocyte recirculation in man. I. Differential regulation of the peripheral lymph node homing receptor L-selectin on T cells during the virgin to memory cell transition. , 1993, Journal of immunology.

[19]  J. Giorgi,et al.  B cell reconstitution after human bone marrow transplantation: recapitulation of ontogeny? , 1993, Bone marrow transplantation.

[20]  A. Nagler,et al.  Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients. , 1993, Bone marrow transplantation.

[21]  P. Linsley,et al.  The role of the CD28 receptor during T cell responses to antigen. , 1993, Annual review of immunology.

[22]  C. Cordonnier,et al.  Immunogenicity of Haemophilus influenzae type b conjugate vaccine in allogeneic bone marrow recipients. , 1992, The Journal of infectious diseases.

[23]  K. Sullivan,et al.  Treatment of acute graft-versus-host disease with a nonmitogenic anti-CD3 monoclonal antibody. , 1992, Transplantation.

[24]  G. Sale,et al.  Abnormal CD4:CD8 ratios and delayed germinal center reconstitution in lymph nodes of human graft recipients with graft-versus-host disease (GVHD): an immunohistological study. , 1992, Experimental hematology.

[25]  J. Storek,et al.  Reconstitution of B cell immunity following bone marrow transplantation. , 1992, Bone marrow transplantation.

[26]  K. Sullivan,et al.  Late complications of allogeneic and autologous marrow transplantation. , 1992, Bone marrow transplantation.

[27]  S. Forman,et al.  Amplification by the polymerase chain reaction of hypervariable regions of the human genome for evaluation of chimerism after bone marrow transplantation , 1991 .

[28]  E. Thomas,et al.  Use of a probe to repeat sequence of the Y chromosome for detection of host cells in peripheral blood of bone marrow transplant recipients. , 1991, American journal of clinical pathology.

[29]  G. Heller,et al.  B-cell differentiation following autologous, conventional, or T-cell depleted bone marrow transplantation: a recapitulation of normal B-cell ontogeny. , 1990, Blood.

[30]  M. Pepe,et al.  Response to tetanus toxoid immunization after allogeneic bone marrow transplantation. , 1990, The Journal of infectious diseases.

[31]  D. Musher,et al.  Pneumococcal polysaccharide vaccine in young adults and older bronchitics: determination of IgG responses by ELISA and the effect of adsorption of serum with non-type-specific cell wall polysaccharide. , 1990, The Journal of infectious diseases.

[32]  B. Blazar,et al.  Use of an anti-pan T-lymphocyte ricin a chain immunotoxin in steroid-resistant acute graft-versus-host disease. , 1990, Blood.

[33]  J. Sheridan,et al.  Immunoglobulin G subclass deficiency and pneumococcal infection after allogeneic bone marrow transplantation. , 1990, Blood.

[34]  J. Phair,et al.  The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group. , 1990, The New England journal of medicine.

[35]  L. Lum Recapitulation of immune ontogeny: a vital component for the success of bone marrow transplantation. , 1990, Cancer treatment and research.

[36]  J. Hansen,et al.  A distinct subset of human CD4+ cells with a limited alloreactive T cell receptor repertoire. , 1989, Journal of immunology.

[37]  R. Champlin,et al.  B-cell dysfunction following human bone marrow transplantation: functional-phenotypic dissociation in the early posttransplant period. , 1989, Blood.

[38]  G. Heller,et al.  Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts , 1989 .

[39]  T. Tötterman,et al.  Regeneration of functional and activated NK and T sub-subset cells in the marrow and blood after autologous bone marrow transplantation: a prospective phenotypic study with 2/3-color FACS analysis. , 1989, Leukemia.

[40]  E. Minar,et al.  Functional asplenia after bone marrow transplantation. A late complication related to extensive chronic graft-versus-host disease. , 1988, Annals of internal medicine.

[41]  H. Deeg,et al.  Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease. , 1988, Blood.

[42]  M. Martelli,et al.  Imbalances within the peripheral blood T-helper (CD4+) and T-suppressor (CD8+) cell populations in the reconstitution phase after human bone marrow transplantation. , 1988, Blood.

[43]  J. Klein,et al.  Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen , 1987 .

[44]  H. Müller-Hermelink,et al.  Pathology of the thymus after allogeneic bone marrow transplantation in man. A histologic immunohistochemical study of 36 patients. , 1987, The American journal of pathology.

[45]  C. Cordonnier,et al.  Long lasting IgG subclass and antibacterial polysaccharide antibody deficiency after allogeneic bone marrow transplantation. , 1987, Blood.

[46]  R. Storb,et al.  Proliferative and differentiative responses of B cells from human marrow graft recipients to T cell-derived factors. , 1987, Blood.

[47]  H. Deeg,et al.  Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease. , 1986, Blood.

[48]  H. Deeg,et al.  Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. , 1986, The New England journal of medicine.

[49]  H. Deeg,et al.  Treatment of human acute graft-versus-host disease with antithymocyte globulin and cyclosporine with or without methylprednisolone. , 1985, Transplantation.

[50]  H. Deeg,et al.  RECOVERY OF IN VIVO CELLULAR IMMUNITY AFTER HUMAN MARROW GRAFTING: Influence of Time Postgrafting and Acute Graft‐Versus‐Host Disease , 1984, Transplantation.

[51]  H. Wagner,et al.  Functional asplenia in patients with chronic graft-versus-host disease: concise communication. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[52]  L. Petz,et al.  Clinical bone marrow transplantation , 1983 .

[53]  K. Sullivan,et al.  Analysis of late infections after human bone marrow transplantation: role of genotypic nonidentity between marrow donor and recipient and of nonspecific suppressor cells in patients with chronic graft-versus-host disease. , 1982, Blood.

[54]  R. Storb,et al.  T-cell subpopulations identified by monoclonal antibodies after human marrow transplantation. I. Helper-inducer and cytotoxic-suppressor subsets , 1982 .

[55]  W. Friedrich,et al.  T-lymphocyte reconstitution in recipients of bone marrow transplants with and without GVHD: imbalances of T-cell subpopulations having unique regulatory and cognitive functions. , 1982, Blood.

[56]  W. Friedrich,et al.  Abnormal humoral immune responses in peripheral blood lymphocyte cultures of bone marrow transplant recipients. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[57]  R. Storb,et al.  In vitro regulation of immunoglobulin synthesis after marrow transplantation. I. T-cell and B-cell deficiencies in patients with and without chronic graft-versus-host disease. , 1981, Blood.

[58]  K. Sullivan,et al.  Recovery of antibody production in human allogeneic marrow graft recipients: influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatment , 1981 .

[59]  R. Storb,et al.  Total-body irradiation in preparation for marrow engraftment. , 1976, Transplantation proceedings.